GL1X · GenesisL1 explorer

MolNFT v1 · #145884 · protein

Q9WV56: AlphaFold monomer V2.0 prediction for GROWTH/DIFFERENTIATION factor 2 (Q9WV56)

Q9WV56: “AlphaFold monomer V2.0 prediction for GROWTH/DIFFERENTIATION factor 2 (Q9WV56)”. 8 pockets (best druggability 0.55). MolNFT v1 #145884 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

3D structure of Q9WV56: AlphaFold monomer V2.0 prediction for GROWTH/DIFFERENTIATION factor 2 (Q9WV56) (MolNFT v1 / AlphaFold)
3D structure of Q9WV56: AlphaFold monomer V2.0 prediction for GROWTH/DIFFERENTIATION factor 2 (Q9WV56) (MolNFT v1 / AlphaFold)
Accession
Q9WV56
Type
protein
Length
428 residues
Chains
1
Deposited
01-JUL-21
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x80D2ac0F5e3268bC5C1d28BBAA07E3169BB02b79
Molecule
GROWTH/DIFFERENTIATION factor 2
UniProt
Q9WV56
Pockets
8 · best druggability 0.55

Structure

1 distinct chain · 18% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGROWTH/DIFFERENTIATION factor 2protein42818% helix, 29% strandQ9WV56

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13490.550.7439empty
21560.530.8025empty
31130.430.7717empty
4510.330.7811empty
5520.330.7816empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4YCI · Non-latent pro-bone morphogenetic protein 9 · an experimental structure of the same protein · chain A against A, TM-score 0.41
  • 4YCI · non-latent pro-bone morphogenetic protein 9 · an experimental structure of the same protein · chain A against A, TM-score 0.41
  • 4YCG · Pro-bone morphogenetic protein 9 · an experimental structure of the same protein · chain A against B, TM-score 0.41
  • 4YCG · Pro-bone morphogenetic protein 9 · an experimental structure of the same protein · chain A against B, TM-score 0.41

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.